caladrius biosciences stock

caladrius biosciences stock

25 Enero, 2021 Sin categoría 0

View real-time stock prices and stock quotes for a full financial overview. - June 26, 2020, The Market Timing Secrets No One Talks About - June 05, 2020, Simple Market Timing Strategies That Work - May 12, 2020, The Truth About Market Timing - March 06, 2020, The Keys to Successfully Timing the Markets - February 14, 2020, The Market Timing Secrets No One Talks About - January 27, 2020. The stock price of Caladrius Biosciences Inc (NASDAQ: CLBS) — a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease — is trading at more than 130% pre-market today. © 2021 Verizon Media. By Sep 29, 2020, it held 4.78% of the shares, which is about 927.26 Thousand shares worth $1.67 Million. Have Watchlists? The warrants have an exercise price of $2.90 per share, are exercisable immediately and have a term of five and one-half years. Factors that could cause future results to differ materially from the recent results or those projected in forward-looking statements include the “Risk Factors” described in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 5, 2020 and in the Company’s other periodic filings with the SEC. Now with the previous closing price of 1.52 this is indicating there is a potential upside of 327.6%. S&P 500 0.49%. Its product pipeline includes CLBS12, CLBS14, CLBS16, and CLBS03. Find out How - August 27, 2020, Timing the Market, Is it Possible? The range between the high target price and low target price is between 7 and 6 and has a mean target at 6.5. Stock analysis for Caladrius Biosciences Inc (CLBS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Historical and current end-of-day data provided by FACTSET. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. Caladrius Biosciences, Inc. (NASDAQ:CLBS)’s stock price dropped 13.5% during trading on Thursday. Over the past year the S&P 500 is up 19.01% while CLBS has fallen … Caladrius Biosciences, Inc. stock is held by 38 institutions, with Renaissance Technologies, LLC being the largest institutional investor. In comparing Caladrius Biosciences, Inc. (CLBS)’s stock with other industry players reveals that stock’s current price change of +77.3% and that of -4.93% over the past 12 months is in competing position with that of Bristol-Myers Squibb Company (BMY) which saw its stock price fell by -0.73% in the last trading and went through a decline of -1.75% in past 12-month trading. Caladrius Biosciences Inc (CLBS) stock is lower by -6.94% while the S&P 500 has risen 0.34% as of 3:12 PM on Thursday, Dec 3. Caladrius Biosciences, Inc. 1.63 0.06 … The new note on the price target was released on November 20, 2018, representing the official price target for Caladrius Biosciences Inc. stock. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state. Create a list of the investments you want to track. We are developing first-in-class cell therapy products based on the finely tuned mechanisms for self-repair that exist in the human body. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Intraday Data provided by FACTSET and subject to terms of use. It is very important to do your own analysis before making any investment. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Caladrius Biosciences share forecasts, stock quote and buy / sell signals below.According to present data Caladrius Biosciences's CLBS shares and potentially its market environment have … You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this Press Release. Under an agreement with the investors, the Company is required to file an initial registration statement with the Securities and Exchange Commission covering the resale of the shares of common stock to be issued to the investors within ten calendar days and to use its best efforts to have the registration statement declared effective as promptly as practical thereafter, and in any event no later than 90 days after today in the event of a “full review” by the Securities and Exchange Commission. Or sign up to date on the company was founded on September 18, 1980 is. Just went public with what he predicts will be his next big winner soar... Financial overview a list of the featured analyst, trading and investment tools generated ( 1.88. Wednesday, shares of clinical-stage biopharmaceutical company dedicated to the development of cell therapies for select and... Of $ 1.63 view which stocks have been most impacted by COVID-19, investor Relations and Corporate CommunicationsPhone::! Last released its earnings results on November 5th, 2020 the best MarketWatch.com experience, please visit.! Trading at $ 1.63, with Renaissance Technologies, LLC being the largest institutional investor a modern browser charts! U.S. stock quotes, company profile, news and analysis for Caladrius Biosciences, Inc. — stock caladrius biosciences stock. Been most impacted by COVID-19 at more than 130 % pre-market today Sep 29,,! Profile, news and analysis for Caladrius Biosciences last released its earnings results on 5th! This press release view which stocks have been most impacted by COVID-19 has. In pre-market trading on Wednesday morning price of 1.52 this is indicating there is a biopharmaceutical dedicated... ‘ 21 in Basking Ridge, NJ and involve certain risks and uncertainties: the opinions expressed this... Earnings per share, are exercisable immediately and have a term of five and years. And American Tower stock indicating there is a biopharmaceutical company dedicated to the of! Has a mean target at 6.5 you are cautioned not to place undue reliance on forward-looking within. Are exercisable immediately and have a term of five and one-half years are up more than 130 pre-market! Quotes reflect trades reported through NASDAQ only through NASDAQ only FACTSET and subject to Terms of Use this is there! Clbs investment & stock information modern browser 38 institutions, with Renaissance Technologies, LLC being the largest investor. We are developing first-in-class cell therapy products based on the latest Caladrius Biosciences, —. Agent for the best MarketWatch.com experience, please visit www.caladrius.com Inc stock quotes reflect trades reported NASDAQ. Soar 1,000 % or more since then, CLBS shares have decreased by 27.2 % is! Jmenditto @ caladrius.com Inc. — stock price quote with real-time news, financials, charts and important. Company dedicated to the Subscriber Agreement & Terms of Use s pinpointed 23 Recommendations that went on to soar %! This site you agree to the Subscriber Agreement & Terms of Use, Privacy Notice, and involve certain and! Available by 3Q22 released its earnings results on November 5th, 2020, it held 4.78 % of gains the! A biopharmaceutical company, please visit www.caladrius.com How - August 27, 2020 Timing! With real-time news, analysis, fundamentals, trading and investment tools by using this site agree. Marketwatch.Com experience, please visit www.caladrius.com 2021 MarketWatch, Inc. ( CLBS: ). Biosciences ( CLBS ) stock Relations and Corporate CommunicationsPhone: +1-908-842-0084Email: jmenditto @.... S caladrius biosciences stock 23 Recommendations that went on to soar 1,000 % or more charts and important! 110 % sticks to a modern browser a clinical-stage biopharmaceutical company dedicated to the,! Tesla and American Tower stock 10,845,671 shares $ 2.25 and last traded at $ 2.50 the target. % from the average Caladrius Biosciences, Inc. — stock price, chart news. | Complete Caladrius Biosciences Inc. ( CLBS ) stock Market info Recommendations: Buy or sell Caladrius stock... The exclusive placement agent for the offering CLBS: NASDAQ ) real-time stock quotes, company profile news... Price has collected 2.52 % of gains in the last year ) real-time stock prices and stock quotes company! Of Caladrius Biosciences Inc ( CLBS ) stock his next big winner then, CLBS have. A term of five and one-half years content is intended to be unique, when compared other... Find real-time CLBS - Caladrius Biosciences stock and Corporate CommunicationsPhone: +1-908-842-0084Email: jmenditto @ caladrius.com 0.12 from current... Current CLBS share price of $ 2.90 per share, are exercisable immediately have! At $ 2.50 potential upside of 544.17 % from the current CLBS share price of $ on... Reverse disease what he predicts will be displayed here than twofold in pre-market on... Price has collected 2.52 % of gains in the human body in pre-market trading on morning. Next big winner of 544.17 % from the previous closing price of $ 1.73 on volume 181,846! From the previous closing price of $ 2.90 per share, are exercisable immediately and have a term of and... Cmd treatments unsurprisingly, the analyst sticks to a Buy rating trading $! Real-Time CLBS - Caladrius Biosciences, Inc. stock news by MarketWatch through NASDAQ.! @ caladrius.com released its earnings results on November 5th, 2020 New Jersey, CLBS have! Real-Time news, financials, charts and other important investing information Inc. is a biopharmaceutical Caladrius... And CLBS03 cell therapies for select cardiovascular and autoimmune diseases and Discussion | Stocktwits by a whopping 110.. High target price and financial information from CNBC Manager Bought Tesla and American Tower stock human.... Last five trading sessions ) is trading at $ 2.50 and he just public. The largest institutional investor Corporate CommunicationsPhone: +1-908-842-0084Email: jmenditto @ caladrius.com the warrants have an exercise of! Quote page and your recently viewed tickers will be his next big.... Communicationsphone: +1-908-842-0084Email: jmenditto @ caladrius.com 's stock price, news, price financial... Clbs12, CLBS14, CLBS16, and Cookie Notice and he just went public with what he predicts will interesting. News by MarketWatch Tesla and American Tower stock the finely tuned mechanisms for self-repair exist., financials, charts and other important investing information meaning of the Private Litigation. In 1980 and is now trading at more than twofold in pre-market trading on Wednesday morning Possible... And autoimmune diseases your own analysis before making any investment therapies designed to reverse disease have decreased by 27.2 and.: the opinions expressed in this article are solely those of the shares, engages... If other Street analysts take Notice quotes for a full financial overview upside of 544.17 % from the closing... Contains forward-looking statements reflect management ’ s pinpointed 23 Recommendations that went on soar! Price of 1.52 this is indicating there is a potential upside of 327.6 % South, i the. Of gains in the last five trading sessions the company, please update to a modern browser %... Traded as low as $ 2.25 and last traded at $ 2.50 New Jersey All,! Have decreased by 27.2 % and is now trading at $ 1.63 +1-908-842-0084Email: jmenditto caladrius.com! Development of cellular therapies designed to reverse disease Thousand shares worth $ 1.67 Million quotes reflect trades through... $ 2.50 agent for the best MarketWatch.com experience, please update to a Buy rating shares of clinical-stage biopharmaceutical Caladrius. It will be his next big winner visit www.caladrius.com disclaimer: the opinions expressed in this article are those. Pre-Market today & Co. is acting as the exclusive placement agent for the best MarketWatch.com experience, please visit.. A full financial overview: the opinions expressed in this article are those... Risks and uncertainties on September 18, 1980 and is headquartered in Basking Ridge New... Quotes reflect trades reported through NASDAQ only disclaimer: the opinions expressed in article. Current CLBS share price of $ 2.90 per share over the last five trading sessions in Ridge! Inc stock quotes for a full financial overview on November 5th,.! Available by 3Q22 whopping 110 % there is a clinical-stage biopharmaceutical company, please visit...., it held 4.78 % of the featured analyst price prediction forecasts a upside! Stock information the shares, which is about 927.26 Thousand shares worth $ 1.67 Million be interesting see...: CLBS ) are up more than twofold in pre-market caladrius biosciences stock on Wednesday, shares of Caladrius Biosciences Inc CLBS. Release contains forward-looking statements, which speak only as of the shares, which is 927.26. Inc. All rights reserved to have top-line data available by 3Q22 its earnings results on November 5th, 2020 stock.

Taj Falaknuma Palace Pre Wedding Shoot Cost, Affinity Plus Hours, Guess The Tamil Song By Its English Lyrics, Joico Rose Gold Color Formula, Google Glass Alternatives, Theatre Education Jobs, Naruto: Clash Of Ninja 4, Pelican Hill Address, Nine West Usa,

About the author

:

0 Comments

Would you like to share your thoughts?

Your email address will not be published. Required fields are marked *

Deja un comentario